SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-21-038452
Filing Date
2021-03-18
Accepted
2021-03-18 17:29:05
Documents
91
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K tm211024-1_10k.htm 10-K 1623156
2 EXHIBIT 10.15.2 tm211024d3_ex10-15d2.htm EX-10.15.2 20835
3 EXHIBIT 21.1 tm211024d3_ex21-1.htm EX-21.1 1820
4 EXHIBIT 23.1 tm211024d3_ex23-1.htm EX-23.1 9696
5 EXHIBIT 31.1 tm211024d3_ex31-1.htm EX-31.1 9663
6 EXHIBIT 31.2 tm211024d3_ex31-2.htm EX-31.2 10076
7 EXHIBIT 32.1 tm211024d3_ex32-1.htm EX-32.1 4904
8 EXHIBIT 32.2 tm211024d3_ex32-2.htm EX-32.2 4838
  Complete submission text file 0001104659-21-038452.txt   8488880

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT ontx-20201231.xml EX-101.INS 1878282
10 XBRL TAXONOMY EXTENSION SCHEMA ontx-20201231.xsd EX-101.SCH 70463
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ontx-20201231_cal.xml EX-101.CAL 54469
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ontx-20201231_def.xml EX-101.DEF 269274
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE ontx-20201231_lab.xml EX-101.LAB 600511
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ontx-20201231_pre.xml EX-101.PRE 475452
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36020 | Film No.: 21755546
SIC: 2834 Pharmaceutical Preparations